IWM
CLVS

IHT Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

IHT Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,200
Closed -$116K – 651
2020
Q1 		$116K Buy
18,200
+400
+2% +$3.21K 0.02% 504
2019
Q4 		$186K Buy
+17,800
New +$129K 0.02% 575

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IHT Wealth Management's CLVS Position: Q2 2020 in Review

IHT Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 18,200 shares — an estimated $116K sold.

IHT Wealth Management first reported a position in CLVS in Q4 2019 and held it in 2 quarters. The position peaked at $186K in Q4 2019. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • IHT Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • IHT Wealth Management sold 18,200 Clovis Oncology, Inc. shares in Q2 2020, an estimated $116K.
  • IHT Wealth Management first reported a position in Clovis Oncology, Inc. in Q4 2019 and held it in 2 quarters.
  • IHT Wealth Management's Clovis Oncology, Inc. position peaked at $186K in Q4 2019.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on IHT Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.